作者
HR Soares, R Castro, HA Tomás, AF Rodrigues, P Gomes-Alves, B Bellier, D Klatzmann, MJT Carrondo, PM Alves, AS Coroadinha
发表日期
2016/3/18
期刊
Vaccine
卷号
34
期号
13
页码范围
1634-1641
出版商
Elsevier
简介
Virus-like particles (VLPs) are a particular subset of subunit vaccines which are currently explored as safer alternatives to live attenuated or inactivated vaccines. VLPs derived from retrovirus (retroVLPs) are commonly used as scaffolds for vaccine candidates due to their ability to incorporate heterologous envelope proteins. Pseudotyping retroVLPs is however not a selective process therefore, host cellular proteins such as tetraspanins are also included in the membrane. The contribution of these host-proteins to retrovirus immunogenicity remains unclear. In this work, human cells silenced and not silenced for tetraspanin CD81 were used to produce CD81 or CD81+ retroVLPs. We first analyzed mice immune response against human CD81. Despite effective silencing of CD81 in retroVLP producing cells, both humoral and cellular immune responses showed persistent anti-CD81 immunogenicity, suggesting cross …
引用总数
2016201720182019202020212022202321542111